RGRomaric Gérardy

Romaric Gérardy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Romaric Gérardy has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Top Cited Papers

    Continuous Flow Upgrading of Selected C2–C6Platform Chemicals Derived from Biomass

    by Romaric Gérardy, Damien P. Debecker, Julien Estager, Patricia Luis, Jean-Christophe M. Monbaliu

    The ever increasing industrial production of commodity and specialty chemicals inexorably depletes the finite primary fossil resources available on Earth. The forecast of population growth over the next 3 decades is a very strong incentive for the identification of alternative primary resources other than petro-based ones. In contrast with fossil resources, renewable biomass is a virtually inexhaustible reservoir of chemical building blocks. Shifting the current industrial paradigm from almost exclusively petro-based resources to alternative bio-based raw materials requires more than vibrant political messages; it requires a profound revision of the concepts and technologies on which industrial chemical processes rely. Only a small fraction of molecules extracted from biomass bears significant chemical and commercial potentials to be considered as ubiquitous chemical platforms upon which a new, bio-based industry can thrive. Owing to its inherent assets in terms of unique process experience, scalability, and reduced environmental footprint, flow chemistry arguably has a major role to play in this context. This review covers a selection of C2 to C6 bio-based chemical platforms with existing commercial markets including polyols (ethylene glycol, 1,2-propanediol, 1,3-propanediol, glycerol, 1,4-butanediol, xylitol, and sorbitol), furanoids (furfural and 5-hydroxymethylfurfural) and carboxylic acids (lactic acid, succinic acid, fumaric acid, malic acid, itaconic acid, and levulinic acid). The aim of this review is to illustrate the various aspects of upgrading bio-based platform molecules toward commodity or specialty chemicals using new process concepts that fall under the umbrella of continuous flow technology and that could change the future perspectives of biorefineries.


  • Versatile and scalable synthesis of cyclic organic carbonates under organocatalytic continuous flow conditions

    by Romaric Gérardy, Julien Estager, Patricia Luis, Damien P. Debecker, Jean-Christophe M. Monbaliu

    A scalable intensified flow process for the preparation of cyclic organic carbonates relying on a cheap ammonium organocatalyst.


  • Continuous flow upgrading of glycerol toward oxiranes and active pharmaceutical ingredients thereof

    by Romain Morodo, Romaric Gérardy, Guillaume Petit, Jean-Christophe M. Monbaliu

    A robust continuous flow procedure for the transformation of bio-based glycerol into high value-added oxiranes (epichlorohydrin and glycidol) is presented. The flow procedure features a central hydrochlorination/dechlorination sequence and provides economically and environmentally favorable conditions involving an organocatalyst and aqueous solutions of hydrochloric acid and sodium hydroxide. Pimelic acid (10 mol%) shows an exceptional catalytic activity (>99% conversion of glycerol, a high selectivity toward 1,3-dichloro-2-propanol and 81% cumulated yield toward intermediate chlorohydrins) for the hydrochlorination of glycerol (140 °C) with 36 wt% aqueous HCl. These conditions are validated on a sample of crude bio-based glycerol. The dechlorination step is effective (quantitative conversion based on glycerol) with concentrated aqueous sodium hydroxide (20 °C) and can be directly concatenated to the hydrochlorination step, hence providing a ca. 2 : 3 separable mixture of glycidol and epichlorohydrin (74% cumulated yield). An in-line membrane separation unit is included downstream, providing usable streams of epichlorohydrin (in MTBE, with an optional concentrator) and glycidol (in water). The scalability of the dechlorination step is then assessed in a commercial pilot-scale continuous flow reactor. Next, bio-based epichlorohydrin is further utilized for the continuous flow preparation of β-amino alcohol active pharmaceutical ingredients including propranolol (hypertension, WHO essential), naftopidil (prostatic hyperplasia) and alprenolol (angina pectoris) within a concatenable two-step procedure using a FDA class 3 solvent (DMSO). This work provides the first example of direct upgrading of bio-based glycerol into high value-added pharmaceuticals under continuous flow conditions.


  • Expedient preparation of active pharmaceutical ingredient ketamine under sustainable continuous flow conditions

    by Victor-Emmanuel H. Kassin, Romaric Gérardy, Thomas Toupy, Diégo Collin, Elena Salvadeo, François Toussaint, Kristof Van Hecke, Jean-Christophe M. Monbaliu

    Continuous flow preparation of antidepressant ketamine and analogs under sustainable conditions.


  • Finding the Perfect Match: A Combined Computational and Experimental Study toward Efficient and Scalable Photosensitized [2 + 2] Cycloadditions in Flow

    by Jason D. Williams, Momoe Nakano, Romaric Gérardy, Juan A. Rincón, Óscar de Frutos, Carlos Mateos, Jean-Christophe M. Monbaliu, C. Oliver Kappe


  • Sustaining the Transition from a Petrobased to a Biobased Chemical Industry with Flow Chemistry

    by Romaric Gérardy, Romain Morodo, Julien Estager, Patricia Luis, Damien P. Debecker, Jean-Christophe M. Monbaliu

    In the current context of transitioning to more sustainable chemical processes, the upgrading of biobased platform molecules (i.e., the chemical transformation of widely available low molecular weight entities from biomass) is attracting significant attention, in particular when combined with enabling continuous flow conditions. The success of this combination is largely due to the ability to explore new process conditions and the perspective of facilitating seamless scalability while maintaining a small overall footprint. This review considers representative continuous flow processes which utilize a selection of currently popular platform molecules that target industrially relevant building blocks, including (a) commodity chemicals, (b) specialty and fine chemicals, and (c) fuels and fuel additives.


  • Solvent-free organocatalytic preparation of cyclic organic carbonates under scalable continuous flow conditions

    by Zhiguo Wang, Romaric Gérardy, Guillaume Gauron, Christian Damblon, Jean-Christophe M. Monbaliu

    A solvent-free organocatalyzed process for the transesterification of dimethyl carbonate (DMC) with 1,2-diols under scalable continuous flow conditions is presented. Process parameters, such as temperature, residence time, DMC/glycerol molar ratio and catalyst loading are optimized for the carbonation of bio-based glycerol using 1,8-diazabicyclo(5.4.0)undec-7-ene (DBU) as a model organocatalyst. The catalytic performance of DBU is next compared with other homogeneous organic superbases including the proton sponge, Verkade's base, guanidines and phosphazenes. 2-tert-Butyl-1,1,3,3-tetramethylguanidine (Barton's base) stands as the most efficient organocatalyst, providing glycerol carbonate at 87% selectivity and 94% conversion within 2 minutes of residence time at 1 mol% loading. Representative examples of polystyrene-supported (PS) organic superbases of the amidine, guanidine and phosphazene-types are also considered as alternative heterogeneous catalysts. PS superbases typically enable up to 80 h of continuous operation with minor deactivation at elevated flow rates. The methodology is amenable to a library of other 1,2-diols, including biomass-derived substrates. Depending on the unique structural features of both substrates and products, either on-line IR or on-line NMR analytical procedures are implemented for real-time qualitative reaction monitoring. A final demonstrator showcases the transposition of the glycerol carbonation to a pilot-scale continuous flow reactor, affording the target cyclic carbonate with a 68.3 mol per day productivity (∼8 kg per day).


  • A versatile biobased continuous flow strategy for the production of 3-butene-1,2-diol and vinyl ethylene carbonate from erythritol

    by Nelly Ntumba Tshibalonza, Romaric Gérardy, Zouheir Alsafra, Gauthier Eppe, Jean-Christophe M. Monbaliu

    A versatile, tunable and robust continuous flow procedure for the deoxydehydration (DODH) of biobased erythritol toward 3-butene-1,2-diol is described. The procedure relies on specific assets of multistep continuous flow processing. Detailed mechanistic and computational studies on erythritol show that either 3-butene-1,2-diol or butadiene are obtained in high selectivity and yield on demand, as a function of the DODH reagent/substrate ratio and of the process parameters. Short reaction times (1–15 min) at high temperature (225–275 °C) and moderate pressure are reported. 3-Butene-1,2-diol is then further converted downstream into its corresponding carbonate, i.e. 4-vinyl-1,3-dioxolan-2-one (vinyl ethylene carbonate), an important industrial building block. The carbonation step uses a supported organocatalyst, and could be directly concatenated to the first DODH step. This unprecedented procedure also relies on a unique combination of on- and off-line analytical protocols for reaction monitoring and product quantification, and offers a biobased strategy toward important industrial building blocks otherwise petrosourced.


  • Top Cited Papers

    Continuous Flow Organic Chemistry: Successes and Pitfalls at the Interface with Current Societal Challenges

    by Romaric Gérardy, Noémie Emmanuel, Thomas Toupy, Victor‐Emmanuel Kassin, Nelly Ntumba Tshibalonza, Michaël Schmitz, Jean‐Christophe M. Monbaliu

    This review intends to provide the reader with a clear and concise overview of how preparative continuous flow organic chemistry could potentially impact on current important societal challenges. These societal challenges include health/well‐being and sustainable development. Continuous flow chemistry has enabled significant advances for the manufacturing of pharmaceuticals, as well as for biomass valorization toward a biosourced chemical industry. Examples related to pharmaceutical production are herein focused on (a) the implementation of flow chemistry to reduce the occurrence of drug shortages, (b) continuous flow manufacturing of orphan drugs, (c) continuous flow preparation of active pharmaceuticals listed on the WHO list of essential medicines and (d) perspectives for the manufacturing of peptide‐based pharmaceuticals. Examples related to sustainable development are focused on the valorization of biosourced platform molecules. Besides positive impacts on societal challenges, this review also illustrates some of the potentially most threatening perspectives of continuous flow technology within the actual context of terrorism and drug abuse.